DUBLIN--(BUSINESS WIRE)--The "Tumor Ablation Market Analysis by Application, by Technology (Microwave Ablation, Cryoablation, Radiofrequency Ablation), by Mode of Treatment, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
Globally rising aging populations, increasing innovations in technology for ablation devices, rising demand for minimally invasive treatments among surgeons and patients due to the advantages of quick recovery, patient comfort, and shorter recovery times, increasing number of hospitals, surgical facilities, and ablation facilities and increase in the number of cancer patients are some of the primary market drivers.
However, the current healthcare reform program in the U.S, and cost containment strategies by respective governments' are expected to restrain the market growth.
Segmentation: Tumor Ablation Market Analysis Report 2021-2029 Application (Revenue, USD Million)
- Kidney Cancer
- Bone Metastasis
- Lung Cancer
- Liver Cancer
- Others
Technology (Revenue, USD Million)
- Microwave Ablation
- Cryoablation
- Radiofrequency (RF) Ablation
- Other Technologies
Mode of Treatment (Revenue, USD Million)
- Laparoscopic Ablation
- Surgical Ablation
- Percutaneous Ablation
By Region (Revenue, USD Million)
North America
- U.S
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Tumor Ablation
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Tumor Ablation Market
7. Market Analysis by Application
8. Market Analysis by Technology
9. Market Analysis by Mode of Treatment
10. Regional Market Analysis
11. North America Tumor Ablation Market
12. Europe Tumor Ablation Market
13. Asia Pacific Tumor Ablation Market
14. Latin America Tumor Ablation Market
15. MEA Tumor Ablation Market
16. Competitor Analysis
17. Company Profiles
18. Conclusion
19. Recommendations
Companies Mentioned
- Angiodynamics (Covidien)
- AngioDynamics Inc. (U.S.)
- Boston Scientific Corporation (U.S.)
- EDAP TMS S.A. (France)
- Ethicon Inc. (US)
- Galil Medical Inc. (U.S.)
- HealthTronics Inc. (U.S.)
- Medtronic Plc (U.S.)
- Mermaid Medical (Denmark)
- Misonix Inc. (US)
- Theraclion (France).
For more information about this report visit https://www.researchandmarkets.com/r/jtiifl
